SYNTHESIS AND BIOLOGICAL ACTIVITY OF PERMETHRINIC ACID ANALOGS
1147
Mass spectrum: m/z 279 [M]+. Found, %: C 56.21;
H 7.38; Cl 25.77. C13H20Cl2O2. Calculated, %: C 55.91;
H 7.16; Cl 25.44. M 279.23.
Ethyl 2-benzyl-3-(2,2-dichlorovinyl)-2-methyl-
cyclopropane-1-carboxylate (VIh). Yield 63% (51%
after chromatographic purification), purity 96%. IR
1
spectrum: ν 1620 cm–1 (C=C). H NMR spectrum, δ,
Ethyl 3-(2,2-dichlorovinyl)-2-ethyl-2-methyl-
cyclopropane-1-carboxylate (VIe). Yield 70% (52%
after chromatographic purification), purity 96%. IR
ppm: c-Me-t-Bzl-c-CHCCl2: 1.13 s (3H, CH3), 1.18
t (3H, CH3), 1.93 d (1H, 1-H), 2.15 t (1H, 3-H), 2.61 d
(1H, CH2Ph), 2.71 d (1H, CH2Ph), 4.05 q (2H, OCH2),
6.29 d (1H, CH=), 7.10–7.24 m (5H, Ph); t-Me-c-Bzl-
c-CHCCl2: 1.04 s (3H, CH3), 1.15 t (3H, CH3), 1.89 d
(1H, 1-H), 2.08 t (1H, 3-H), 2.9 d (1H, CH2Ph), 3.08 d
(1H, CH2Ph), 4.05 q (2H, OCH2), 6.49 d (1H, CH=),
7.09–7.23 m (5H, Ph); c-Me-t-Bzl-t-CHCCl2: 1.08 s
(3H, CH3), 1.18 t (3H, CH3), 1.85 d (1H, 1-H), 2.27 t
(1H, 3-H), 2.60 d (1H, CH2Ph), 2.67 d (1H, CH2Ph),
4.07 q (2H, OCH2), 5.69 d (1H, CH=), 7.12–7.26 m
(5H, Ph); t-Me-c-Bzl-t-CHCCl2: 1.00 s (3H, CH3),
1.18 t (3H, CH3), 1.66 d (1H, 1-H), 2.48 t (1H, 3-H),
2.84 d (1H, CH2Ph), 2.95 d (1H, CH2Ph), 4.07 q
(2H, OCH2), 5.53 d (1H, CH=), 7.12–7.26 m (5H, Ph).
13C NMR spectrum, δC, ppm: c-Me-t-Bzl-c-CHCCl2:
13.0, 14.2, 30.2, 30.7, 31.6, 47.1, 60.6, 120.8, 124.8,
126.7–137.8, 170.9; t-Me-c-Bzl-c-CHCCl2: 14.4, 25.7,
29.1, 31.8, 32.8, 34.0, 60.4, 121.0, 124.9, 126.5–137.9,
171.0; c-Me-t-Bzl-t-CHCCl2: 14.4, 17.4, 32.2, 32.8,
34.5, 42.0, 60.9, 122.2, 126.5–138.5, 126.6, 171.2;
t-Me-c-Bzl-t-CHCCl2: 14.5, 19.9, 32.4, 33.4, 34.7,
38.9, 60.7, 122.3, 126.5–138.5, 126.9, 171.1. Mass
spectrum: m/z 313 [M]+. Found, %: C 61.55; H 6.09;
Cl 22.99. C16H18Cl2O2. Calculated, %: C 61.34; H 5.75;
Cl 22.68. M 313.24.
1
spectrum: ν 1619 cm–1 (C=C). H NMR spectrum, δ,
ppm: c-Me-t-Et-c-CHCCl2: 0.82 t (3H, CH3), 1.04 s
(3H, CH3), 1.12 t (3H, CH3), 1.24 m (2H, CH2), 1.65 d
(1H, 1-H), 1.87 t (1H, 3-H), 4.09 q (2H, OCH2), 6.20 d
(1H, CH=); t-Me-c-Et-c-CHCCl2: 0.82 t (3H, CH3),
1.04 s (3H, CH3), 1.18 t (3H, CH3), 1.73 d (1H, 1-H),
1.92 t (1H, 3-H), 4.03 q (2H, OCH2), 6.24 d (1H,
CH=); c-Me-t-Et-t-CHCCl2: 0.80 t (3H, CH3), 1.05 s
(3H, CH3), 1.07 t (3H, CH3), 1.17 m (1H, CH2), 1.28 m
(1H, CH2), 1.42 d (1H, 1-H), 2.04 m (1H, 3-H), 3.95 q
(2H, OCH2), 5.44 d (1H, CH=). 13C NMR spectrum,
δC, ppm: c-Me-t-Et-c-CHCCl2: 10.4, 11.7, 14.3, 30.6,
32.2, 32.9, 35.5, 60.3, 120.3, 124.9, 171.2; t-Me-c-Et-
c-CHCCl2: 10.5, 14.2, 24.9, 31.1, 31.6, 32.4, 35.1,
60.2, 120.2, 125.0, 170.4; c-Me-t-Et-t-CHCCl2: 10.6,
14.3, 16.4, 29.5, 32.9, 33.6, 34.4, 60.5, 121.5, 127.09,
170.8. Mass spectrum: m/z 251 [M]+. Found, %:
C 52.90; H 6.64; Cl 28.56. C11H16Cl2O2. Calculated,
%: C 52.58; H 6.37; Cl 28.28. M 251.17.
Ethyl 2-(2,2-dichlorovinyl)spiro[2.4]heptane-1-
carboxylate (VIf). Yield 58% (44% after chromato-
graphic purification), purity 95%. IR spectrum:
1
ν 1615 cm–1 (C=C). H NMR spectrum, δ, ppm: 1.27 t
(3H, CH3), 1.56 d (1H, 1-H), 1.69 m (4H, CH2), 1.73 d
(2H, CH2), 1.79 t (2H, CH2), 2.38 d.d (1H, 2-H),
4.15 q (2H, OCH2), 5.52 d (1H, CH=). 13C NMR spec-
trum, δC, ppm: 14.3, 25.5, 26.2, 29.9, 32.1, 33.1, 34.1,
36.2, 60.4, 121.4, 126.9, 170.3. Mass spectrum:
m/z 263 [M]+. Found, %: C 54.46; H 5.82; Cl 27.38.
C12H16Cl2O2. Calculated, %: C 54.75; H 6.08; Cl 26.99.
M 263.13.
Ethyl 2-benzyl-3-(2,2-dichlorovinyl)-2-ethyl-
cyclopropane-1-carboxylate (VIi). Yield 59% (45%
after chromatographic purification), purity 95%. IR
1
spectrum: ν 1620 cm–1 (C=C). H NMR spectrum, δ,
ppm: c-Et-t-Bzl-c-CHCCl2: 0.85 t (3H, CH3), 1.18 t
(3H, CH3), 1.44 m (1H, CH2), 1.50 m (1H, CH2),
1.83 d (1H, 1-H), 2.12 t (1H, 3-H), 2.60 d (1H,
CH2Ph), 2.77 d (1H, CH2Ph), 4.02 q (2H, OCH2),
6.33 d (1H, CH=), 7.09–7.25 m (5H, Ph); c-Bzl-t-Et-c-
CHCCl2: 0.83 t (3H, CH3), 1.07 m (1H, CH2), 1.18 t
(3H, CH3), 1.38 m (1H, CH2), 1.85 d (1H, 1-H), 2.06 t
(1H, 3-H), 2.92 d (1H, CH2Ph), 3.05 d (1H, CH2Ph),
4.05 q (2H, OCH2), 6.45 d (1H, CH=), 7.02–7.20 m
(5H, Ph); c-Et-t-Bzl-t-CHCCl2: 0.82 t (3H, CH3),
1.14 t (3H, CH3), 1.35 m and 1.42 m (1H each, CH2),
1.80 d (1H, 1-H), 2.25 t (1H, 3-H), 2.66 m (1H,
CH2Ph), 2.68 m (1H, CH2Ph), 4.08 q (2H, OCH2),
5.65 d (1H, CH=), 7.09–7.23 m (5H, Ph); c-Bzl-t-Et-t-
CHCCl2: 0.83 t (3H, CH3), 1.18 t (3H, CH3), 1.20 m
(1H, CH2), 1.25 m (1H, CH2), 1.68 d (1H, 1-H),
Ethyl 2-(2,2-dichlorovinyl)spiro[2.5]octane-1-
carboxylate (VIg). Yield 57% (44% after chromato-
graphic purification), purity 96%. IR spectrum:
1
ν 1615 cm–1 (C=C). H NMR spectrum, δ, ppm: 1.07 t
(3H, CH3), 1.36 m (2H, 6-H), 1.47 m (1H, 4-H or
8-H), 1.48 m (2H, 5-H or 7-H), 1.53 m (2H, 5-H or
7-H), 1,59 m (1H, 8-H or 4-H), 1.61 m (1H, 4-H or
8-H), 1.63 m (1H, 8-H or 4-H), 1.69 m (1H, 1-H),
2.24 d.d (1H, 2-H), 4.11 q (2H, OCH2), 5.59 d (1H,
CH=). 13C NMR spectrum, δC, ppm: 14.32, 25.4, 25.5,
26.0, 29.9, 32.5, 32.6, 33.0, 36.9, 60.4, 121.9, 126.5,
170.4. Mass spectrum: m/z 277 [M]+. Found, %:
C 56.08; H 6.15; Cl 24.67. C13H18Cl2O2. Calculated,
%: C 56.31; H 6.49; Cl 25.63. M 277.21.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 44 No. 8 2008